The U.S. Food and Drug Administration (FDA) recently approved liraglutide (Saxenda, Victoza) as a treatment for adolescents who are obese. The medicine adds a third option for adolescents who want to try medication to treat obesity.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045